DIAXEMET XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diaxemet xr 1000 metformin hydrochloride 1000 mg extended release tablet blister pack

pharmacor pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; povidone; hypromellose; carmellose sodium; copovidone; magnesium stearate - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

DIAXEMET XR 750 metformin hydrochloride 750 mg extended release tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

diaxemet xr 750 metformin hydrochloride 750 mg extended release tablet bottle pack

pharmacor pty ltd - metformin hydrochloride, quantity: 750 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; copovidone; carmellose sodium; hypromellose; magnesium stearate - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

DIAXEMET XR 1000 metformin hydrochloride 1000 mg extended release tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

diaxemet xr 1000 metformin hydrochloride 1000 mg extended release tablet bottle pack

pharmacor pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: hypromellose; microcrystalline cellulose; copovidone; magnesium stearate; carmellose sodium; povidone - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

PHARMACOR METFORMIN XR 1000 metformin hydrochloride 1000 mg extended release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor metformin xr 1000 metformin hydrochloride 1000 mg extended release tablet blister pack

pharmacor pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; hypromellose; carmellose sodium; magnesium stearate; copovidone - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

DIAXEMET XR 500 metformin hydrochloride 500 mg extended release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diaxemet xr 500 metformin hydrochloride 500 mg extended release tablet blister pack

pharmacor pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: carmellose sodium; hypromellose; microcrystalline cellulose; magnesium stearate; copovidone - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

PHARMACOR METFORMIN XR 1000 metformin hydrochloride 1000 mg extended release tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor metformin xr 1000 metformin hydrochloride 1000 mg extended release tablet bottle pack

pharmacor pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: hypromellose; copovidone; povidone; magnesium stearate; carmellose sodium; microcrystalline cellulose - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin hcl extended release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

APO-Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.